WraSer Pharmaceuticals Revenue and Competitors

Ridgeland, MS USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • WraSer Pharmaceuticals's estimated annual revenue is currently $7.8M per year.(i)
  • WraSer Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • WraSer Pharmaceuticals has 39 Employees.(i)
  • WraSer Pharmaceuticals grew their employee count by -13% last year.

WraSer Pharmaceuticals's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Director, Commercial OperationsReveal Email/Phone
3
Director, Commercial OperationsReveal Email/Phone
4
Director National AccountsReveal Email/Phone
5
Southeast District ManagerReveal Email/Phone
6
Senior Territory ManagerReveal Email/Phone
7
Human ResourcesReveal Email/Phone
8
Professional Sales RepresentativeReveal Email/Phone
9
President / CEOReveal Email/Phone
10
Finance Manager/ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$28.9M14412%N/AN/A
#2
$5.6M284%N/AN/A
#3
$3.6M18-68%N/AN/A
#4
$63.5M3165%N/AN/A
#5
$0.4M2-93%N/AN/A
#6
$7.8M39-13%N/AN/A
#7
$12.7M630%N/AN/A
#8
$11.3M56155%N/AN/A
Add Company

What Is WraSer Pharmaceuticals?

WraSer Pharmaceuticals is an emerging pharmaceutical company that identifies, develops, and markets proprietary pharmaceutical products to physicians and pharmacies throughout the United States. WraSer\'s professional, results-oriented staff, combined with our strategic business alliances and innovative sales model have established WraSer as a pace setter in its market category. Founded in 2002, WraSer Pharmaceuticals is committed to bringing proprietary products to market each year and expanding it sales force annually. WraSer will continue to leverage its collective Upper and Lower Respiratory, Dermatology, and Pain Management expertise to keep developing a portfolio of innovative, therapeutically safe and effective products.

keywords:N/A

N/A

Total Funding

39

Number of Employees

$7.8M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

WraSer Pharmaceuticals News

2022-04-20 - Global Dexamethasone Sodium Phosphate Preparation ...

... WraSer Pharmaceuticals; Mylan; Bound Tree Medical; KingYork; Lingrui Pharmaceutical; North China Pharmaceutical; Shanghai Shyndec Pharmaceutical...

2022-04-17 - Opioid MU Receptor Agonist Market Outlook: Post Covid-19 ...

Hikma Pharmaceuticals PLC, ALLERGAN, Piramal Critical Care, DAIICHI SANKYO ... Pfizer Inc., Mylan N.V., Purdue Pharma L.P., WraSer LLC.

2022-03-22 - Ear Infection Treatment Market growth to accelerate at 5.44 ...

Sun Pharmaceutical Industries Ltd. Wockhardt Ltd. WraSer Pharmaceuticals; Pfizer Inc. F. Hoffmann La Roche Ltd. Know about other key driving...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.7M400%N/A
#2
N/A403%N/A
#3
$8.9M413%N/A
#4
$9.5M4132%N/A
#5
$8.9M415%N/A